tazorac

Generic: tazarotene

Labeler: almirall, llc
NDC Directory HUMAN PRESCRIPTION DRUG NDA Inactive Finished

Drug Facts

Product Profile

Brand Name tazorac
Generic Name tazarotene
Labeler almirall, llc
Dosage Form GEL
Routes
CUTANEOUS
Active Ingredients

tazarotene 1 mg/g

Manufacturer
Almirall, LLC

Identifiers & Regulatory

Product NDC 16110-042
Product ID 16110-042_7e6df473-8f69-4d67-bd06-a24f35ab0a62
Product Type HUMAN PRESCRIPTION DRUG
Marketing Category NDA
Application Number NDA020600
Listing Expiration 2026-12-31
Marketing Start 2020-02-21

Pharmacologic Class

Established (EPC)
retinoid [epc]
Chemical Structure
retinoids [cs]

Normalized Code Variants

Searchable formats for this product NDC code

Digits Only 16110042
Hyphenated Format 16110-042

Supplemental Identifiers

RxCUI
212437 212438 313199 313201
UPC
0316110042107 0316110042305 0316110833309 0316110833101
UNII
81BDR9Y8PS
NUI
N0000175607 M0018962

Packaging Origin

Original Packager
true

Resolved Product View

Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.

Resolved Identity

Brand Name tazorac (source: ndc)
Generic Name tazarotene (source: ndc)
Application Number NDA020600 (source: ndc)
Routes
CUTANEOUS
source: ndc

Resolved Composition

Strengths
  • 1 mg/g
source: ndc
Packaging
  • 1 TUBE in 1 CARTON (16110-042-10) / 100 g in 1 TUBE
  • 1 TUBE in 1 CARTON (16110-042-30) / 30 g in 1 TUBE
source: ndc

Packages (2)

16110-042-10 1 TUBE in 1 CARTON (16110-042-10) / 100 g in 1 TUBE 16110-042-30 1 TUBE in 1 CARTON (16110-042-30) / 30 g in 1 TUBE

Ingredients (1)

tazarotene (1 mg/g)

Linked Drug Pages (1)

Tazorac ndc-match (0.9)

Raw FDA Data

View complete raw FDA NDC JSON payload 
{"route": ["CUTANEOUS"], "spl_id": "7e6df473-8f69-4d67-bd06-a24f35ab0a62", "openfda": {"nui": ["N0000175607", "M0018962"], "upc": ["0316110042107", "0316110042305", "0316110833309", "0316110833101"], "unii": ["81BDR9Y8PS"], "rxcui": ["212437", "212438", "313199", "313201"], "spl_set_id": ["4e4e4b81-420e-4492-8a74-80b692a80057"], "pharm_class_cs": ["Retinoids [CS]"], "pharm_class_epc": ["Retinoid [EPC]"], "manufacturer_name": ["Almirall, LLC"], "is_original_packager": [true]}, "finished": true, "packaging": [{"sample": false, "description": "1 TUBE in 1 CARTON (16110-042-10)  / 100 g in 1 TUBE", "package_ndc": "16110-042-10", "marketing_start_date": "20200221"}, {"sample": false, "description": "1 TUBE in 1 CARTON (16110-042-30)  / 30 g in 1 TUBE", "package_ndc": "16110-042-30", "marketing_start_date": "20200221"}], "brand_name": "Tazorac", "product_id": "16110-042_7e6df473-8f69-4d67-bd06-a24f35ab0a62", "dosage_form": "GEL", "pharm_class": ["Retinoid [EPC]", "Retinoids [CS]"], "product_ndc": "16110-042", "generic_name": "tazarotene", "labeler_name": "Almirall, LLC", "product_type": "HUMAN PRESCRIPTION DRUG", "brand_name_base": "Tazorac", "active_ingredients": [{"name": "TAZAROTENE", "strength": "1 mg/g"}], "application_number": "NDA020600", "marketing_category": "NDA", "marketing_start_date": "20200221", "listing_expiration_date": "20261231"}